A randomized trial on the optimization of 18F-FDG myocardial uptake suppression: Implications for vulnerable coronary plaque imaging

Journal of Nuclear Medicine

Volumn 55, Issue 10, 2014, Pages 1629-1635

  Demeure, Fabian ^a   Hanin, François Xavier ^a   Bol, Anne ^a   Vincent, Marie Françoise ^a   Pouleur, Anne Catherine ^a   Gerber, Bernhard ^a   Pasquet, Agnès ^a   Jamar, François ^a   Vanoverschelde, Jean Louis J ^a   Vancraeynest, David ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

18F FDG PET CT; Calcium channel blocker; Free fatty acids; Inflammation; Vulnerable coronary plaque

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; FATTY ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; VERAPAMIL; LIPID; OLIVE OIL; VEGETABLE OIL;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD ANALYSIS; BLOOD SAMPLING; CALCIUM CELL LEVEL; CARDIAC IMAGING; CARDIOVASCULAR DISEASE; COLORIMETRY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOGENOLYSIS; GLYCOLYSIS; HEART RATE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; LIPID DIET; LOW CARBOHYDRATE DIET; MALE; MORTALITY; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROCESS OPTIMIZATION; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SYSTOLIC BLOOD PRESSURE; ADULT; BLOOD; CHEMISTRY; CORONARY BLOOD VESSEL; DIET; INFLAMMATION; NORMAL HUMAN; PATHOLOGY; PROCEDURES; PROSPECTIVE STUDY; REPRODUCIBILITY; SCINTISCANNING; TIME;

ADULT; CORONARY VESSELS; DIET; FATTY ACIDS, NONESTERIFIED; FEMALE; FLUORODEOXYGLUCOSE F18; HEALTHY VOLUNTEERS; HUMANS; INFLAMMATION; LIPIDS; MALE; PLANT OILS; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; VERAPAMIL;

EID: 84907482437     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.114.138594     Document Type: Article

References (28)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics: 2013 update - a report from the American Heart Association. Circulation. 2013;127: e6-e245.
2. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol. 2006;47:C7-C12.
3. Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
4. Vancraeynest D, Pasquet A, Roelants V, Gerber BL, Vanoverschelde J-L. Imaging the vulnerable plaque. J Am Coll Cardiol. 2011;57:1961-1979.
5. Ogawa M, Ishino S, Mukai T, et al. 18F-FDG accumulation in atherosclerotic plaques: immunohistochemical and PET imaging Study. J Nucl Med. 2004;45: 1245-1250.
6. Tawakol A, Migrino RQ, Bashian GG, et al. In vivo 18Ffluorodeoxyglucose positron emission tomography imaging provides a non-invasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol. 2006;48:1818-1824.
7. Depre C, Vanoverschelde JL-J, Taegtmeyer H. Glucose for the heart. Circulation. 1999;99:578-588.
8. Cheng VY, Slomka PJ, Ahlen M, et al. Impact of carbohydrate restriction with and without fatty acid loading on myocardial 18F-FDG uptake during PET: a randomized controlled trial. J Nucl Cardiol. 2010;17:286-291.
9. Wykrzykowska J, Lehman S, Williams G, et al. Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation. J Nucl Med. 2009;50:563-568.
10. Williams G, Kolodny GM. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. AJR. 2008;190:W151-W156.
11. Gaeta C, Fernández Y, Pavía J, et al. Reduced myocardial 18F-FDG uptake after calcium channel blocker administration: initial observation for a potential new method to improve plaque detection. Eur J Nucl Med Mol Imaging. 2011;38:2018-2024.
12. Rogers IS, Nasir K, Figueroa AL, et al. Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. JACC Cardiovasc Imaging. 2010;3:388-397.
13. Cheng VY, Slomka PJ, Le Meunier L, et al. Coronary arterial 18F-FDG uptake by fusion of PET and coronary CT angiography at sites of percutaneous stenting for acute myocardial infarction and stable coronary artery disease. J Nucl Med. 2012;53:575-583.
14. Nitta Y, Tahara N, Tahara A, et al. Pioglitazone decreases coronary artery inflammation in impaired glucose tolerance and diabetes mellitus: evaluation by FDG-PET/CT imaging. JACC Cardiovasc Imaging. 2013;6:1172-1182.
15. Boellaard R, Hristova I, Ettinger S, et al. EARL FDG-PET/CT accreditation program: Feasibility, overview and results of first 55 successfully accredited sites [abstract]. J Nucl Med. 2013;54(suppl 2):498P-499P.
16. International Commission on Radiological Protection (ICRP). Radiation dose to patients from radiopharmaceuticals: addendum 3 to ICRP publication 53. ICRP publication 106. Approved by the Commission in October 2007. Ann ICRP. 2008;38:1-197.
17. Gaemperli O, Shalhoub J, Owen DRJ, et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J. 2012;33:1902-1910.
18. Joshi NV, Vesey AT, Williams MC, et al. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383:705-713.
19. Tahara N, Kai H, Kakaura H, et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J. 2007;28:2243-2248.
20. Folco EJ, Sheikine Y, Rocha VZ, et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol. 2011;58:603-614.
21. Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET/CT indentifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med. 2009;50:1611-1620.
22. Figueroa AL, Abdelbaky A, Truong QA, et al. Measurement of arterial activity on routine FDG PET/CT images improves prediction of risk of future CVevents. JACC Cardiovasc Imaging. 2013;6:1250-1259.
23. Coulden R, Chung P, Sonnex E, et al. Suppression of myocardial 18F-FDG uptake with a preparatory "Atkins-style" low-carbohydrate diet. Eur Radiol. 2012;22: 2221-2228.
24. Rudd JHF, Narula J, Strauss HW, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol. 2010;55:2527-2535.
25. Deichen JT, Prante O, Gack M, et al. Uptake of (18F)fluorodeoxyglucose in human monocyte-macrophages in vitro. Eur J Nucl Med Mol Imaging. 2003; 30:267-273.
26. Ishimaru S, Tsujino I, Takei T, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J. 2005;26:1538-1543.
27. Menezes LJ, Kotze CW, Hutton BF, et al. Vascular inflammation imaging with 18F-FDG PET/CT: when to image? J Nucl Med. 2009;50:854-857.
28. Kates AM, Herrero P, Dence C, et al. Impact of aging on substrate metabolism by the human heart. J Am Coll Cardiol. 2003;41:293-299.